CROSSJECT is using its world-leading needle-free injection system, ZENEO®, to develop a pipeline of high value supergeneric drugs.

These products, which are based on well-known injectable drugs are designed to enhance patient safety, compliance and comfort.

CROSSJECT develops a product portfolio that combines well-known drugs with an innovative mode of injection.

It is particularly well suited to emergency situation and most chronic treatments, and can be adapted to a wide range of specific situations.


6, rue Pauline Kergomard

Dijon City, Bourgogne-Franche-Comte Region 21300

Get Directions

Upgrade Your Listing